Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with the Combined Pegylated Interferon-Ribavirin Therapy-Reference-Cited by-同舟云学术

Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with the Combined Pegylated Interferon-Ribavirin Therapy

Published:2016-09 Issue:9 Volume:36 Page:527-533
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Hamza Iman¹,Eid Yara²,El-Sayed Mohammad¹,Marzaban Raghda¹,Abdul-Kareem Shaimaa³

Affiliation:

1. Infectious Diseases and Endemic Hepatogastroenterology, Faculty of Medicine, Cairo University, Cairo, Egypt.

2. Endocrinology and Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

3. Hepatogastroenterology Department, Boulak Al-Dakrour Hospital, Cairo, Egypt.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2016.0007

Reference41 articles.

1. Thyroid Function in Patients with Chronic Hepatitis C Virus Infection under Interferon Therapy

2. AkenoN, TomerY. 2007. In Dissecting the Mechanisms of Interferon-Induced Thyroiditis (IIT): Direct Efects of Interferon Alpha on Thyroid Epithelial Cells. Toronto, Canada: 89th Annual Meeting of the Endocrine Society.

3. Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review

4. The management of side-effects during therapy for hepatitis C

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of endocrine-related adverse events associated with interferon;Frontiers in Endocrinology;2022-08-05

2. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin;Pediatric Infectious Disease Journal;2018-04

3. Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015);Expert Opinion on Therapeutic Patents;2017-01-10